SML2472
UPGL00004
≥98% (HPLC)
别名:
2-Phenyl-N-(5-(4-((5-(2-phenylacetamido)-1,3,4-thiadiazol-2-yl)amino)piperidin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide, N-[5-[4-[[5-[(2-Phenylacetyl)amino]-1,3,4-thiadiazol-2-yl]amino]-1-piperidinyl]-1,3,4-thiadiazol-2-yl]benzeneacetamide
InChI
1S/C25H26N8O2S2/c34-20(15-17-7-3-1-4-8-17)27-23-30-29-22(36-23)26-19-11-13-33(14-12-19)25-32-31-24(37-25)28-21(35)16-18-9-5-2-6-10-18/h1-10,19H,11-16H2,(H,26,29)(H,27,30,34)(H,28,31,35)
InChI key
MRYCNTHLPRENBA-UHFFFAOYSA-N
SMILES string
O=C(CC1=CC=CC=C1)NC(S2)=NN=C2N(CC3)CCC3NC4=NN=C(NC(CC5=CC=CC=C5)=O)S4
assay
≥98% (HPLC)
form
powder
color
white to pink
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Biochem/physiol Actions
UPGL00004, a BPTES analog, is an orally available, potent and selective inhibitor of glutaminase C (GAC) that potently inhibits the growth of triplenegative breast cancer cells. UPGL00004 directly binds to the allosteric site at GAC.
orally available, potent and selective inhibitor of glutaminase C (GAC)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持